Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13341| Title: | Angiotensin converting enzyme inhibitors in perspective: an update. | Austin Authors: | Burrell, Louise M ;Johnston, Colin I | Affiliation: | General Medicine | Issue Date: | 1-Jul-1993 | Publication information: | Australian Family Physician; 22(7): 1243-7, 1251, 1255 | Abstract: | Orally active inhibitors of angiotensin converting enzyme (ACE) have made a major impact on the clinical therapy of hypertension, congestive cardiac failure and ventricular remodelling after myocardial infarction. The ACE inhibitors combine the advantages of efficacy and low incidence of side effects, with the promise of cardio-, vasculo- and reno- protection. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/13341 | ORCID: | Journal: | Australian Family Physician | URL: | https://pubmed.ncbi.nlm.nih.gov/8373316 | Type: | Journal Article | Subjects: | Age Factors Angiotensin-Converting Enzyme Inhibitors.pharmacology.therapeutic use Diabetic Nephropathies.drug therapy Drug Therapy, Combination Heart Diseases.drug therapy Hemodynamics.drug effects Humans Hypertension.drug therapy Hypertension, Renal.drug therapy Hypertension, Renovascular.drug therapy |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.